Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 330.85 INR 0.33%
Market Cap: 30.5B INR
Have any thoughts about
Indoco Remedies Ltd?
Write Note

Indoco Remedies Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Indoco Remedies Ltd
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Indoco Remedies Ltd
NSE:INDOCO
Operating Expenses
-â‚ą10.3B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Expenses
-â‚ą146.4B
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Expenses
-â‚ą121.4B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
-9%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Expenses
-â‚ą285.7B
CAGR 3-Years
-14%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Expenses
-â‚ą56.9B
CAGR 3-Years
-12%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
M
Mankind Pharma Ltd
NSE:MANKIND
Operating Expenses
-â‚ą47.9B
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Indoco Remedies Ltd
Glance View

Market Cap
30.5B INR
Industry
Pharmaceuticals

Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

INDOCO Intrinsic Value
409.51 INR
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Indoco Remedies Ltd's Operating Expenses?
Operating Expenses
-10.3B INR

Based on the financial report for Mar 31, 2024, Indoco Remedies Ltd's Operating Expenses amounts to -10.3B INR.

What is Indoco Remedies Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-11%

Over the last year, the Operating Expenses growth was -19%. The average annual Operating Expenses growth rates for Indoco Remedies Ltd have been -15% over the past three years , -11% over the past five years .

Back to Top